
|Articles|March 1, 2004
Gray areas continue to impede the use of specialty drugs and injectables
Using expensive drugs without assurances of necessity and greater efficacy can threaten plans' ability to provide other necessary care
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Medicare Part D redesign reshapes market
2
The sleep doctor who lives with a disorder he treats
3
A conversation with Tiffany Phung, Pharm.D., CSP, about how patient outcomes drive specialty pharmacy strategy
4
Recombinant shingles vaccine linked to lower cardiovascular disease risk
5













